Bioengineered Stents Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Bioengineered Stents Market to 2027 - Global Analysis and Forecasts By Application (Coronary Artery Disease, Peripheral Arterial Disease, Carotid Artery Disease, Renal Artery Stenosis, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and others); Product (Drug-eluting Stents, Bio absorbable Stents and Drug-Eluting Balloons); Mode of Delivery (Balloon-expandable stents and Self-expanding stents); Material (Metal-based and Polymer-based); End User (Hospitals cardiac centers, Ambulatory Surgical Centers and others)

Report Code: TIPRE00003729 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Bioengineered Stents are used to treat blockage of coronary and peripheral artery, related to heart disease, ischemic heart disease and other cardiovascular diseases. The antibody on the stent's surface attracts circulating Endothelial Progenitor Cells coming from human bone marrow helping a speedy formation of healthy endothelium.

MARKET DYNAMICS
The Bioengineered Stents market is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of cardiovascular disease, coronary heart disease and increasing number of geriatric population. Nevertheless, the availability of alternative treatments of cardiac diseases and stringent regulations for product approvals are expected to hinder the market growth.

MARKET SCOPE
The "Global Bioengineered Stents Market Analysis to 2027" is a specialized and in-depth study of the Biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Bioengineered Stents market with detailed market segmentation by Application, Product, Mode of Delivery, Material, End User and Geography. The global Bioengineered Stents market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Bioengineered Stents market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Bioengineered Stents market is segmented on the basis of by Application, Product, Mode of Delivery, Material and End User. On the basis of Application the market is segmented as Coronary Artery Disease, Peripheral Arterial Disease, Carotid Artery Disease, Renal Artery Stenosis, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and others. On the basis of Product the market is segmented as Drug-eluting Stents, Bio absorbable Stents and Drug-Eluting Balloons. On the basis of Mode of Delivery the market is segmented as Balloon-expandable stents and Self-expanding stents. On the basis of material type the market is segmented as Metal-based and Polymer-based. On the basis of End-User the market is segmented as Hospitals cardiac centers, Ambulatory Surgical Centers and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Bioengineered Stents market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Bioengineered Stents market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Bioengineered Stents market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Bioengineered Stents market in these regions.

MARKET PLAYERS
The reports cover key developments in the Bioengineered Stents Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Bioengineered Stents Market are anticipated to lucrative growth opportunities in the future with the rising demand for Bioengineered Stents in the global market. Below mentioned is the list of few companies engaged in the Bioengineered Stents market.

The report also includes the profiles of key Bioengineered Stents market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Braun Melsungen AG
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Stentys SA
  • Meril Life Sciences Pvt. Ltd
  • Vascular Concepts
  • L. Gore and Associates
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bioengineered Stents Market - By Application
1.3.2 Bioengineered Stents Market - By Product
1.3.3 Bioengineered Stents Market - By Mode of Delivery
1.3.4 Bioengineered Stents Market - By Material
1.3.5 Bioengineered Stents Market - By End User
1.3.6 Bioengineered Stents Market - By Region
1.3.6.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. BIOENGINEERED STENTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOENGINEERED STENTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOENGINEERED STENTS MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOENGINEERED STENTS - GLOBAL MARKET OVERVIEW
6.2. BIOENGINEERED STENTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOENGINEERED STENTS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. CORONARY ARTERY DISEASE
7.3.1. Overview
7.3.2. Coronary Artery Disease Market Forecast and Analysis
7.4. PERIPHERAL ARTERIAL DISEASE
7.4.1. Overview
7.4.2. Peripheral Arterial Disease Market Forecast and Analysis
7.5. CAROTID ARTERY DISEASE
7.5.1. Overview
7.5.2. Carotid Artery Disease Market Forecast and Analysis
7.6. RENAL ARTERY STENOSIS
7.6.1. Overview
7.6.2. Renal Artery Stenosis Market Forecast and Analysis
7.7. ABDOMINAL AORTIC ANEURYSM
7.7.1. Overview
7.7.2. Abdominal Aortic Aneurysm Market Forecast and Analysis
7.8. THORACIC AORTIC ANEURYSM AND OTHERS
7.8.1. Overview
7.8.2. Thoracic Aortic Aneurysm and others Market Forecast and Analysis
8. BIOENGINEERED STENTS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. DRUG-ELUTING STENTS
8.3.1. Overview
8.3.2. Drug-eluting Stents Market Forecast and Analysis
8.4. BIO ABSORBABLE STENTS AND DRUG-ELUTING BALLOONS
8.4.1. Overview
8.4.2. Bio absorbable Stents and Drug-Eluting Balloons Market Forecast and Analysis
9. BIOENGINEERED STENTS MARKET - REVENUE AND FORECASTS TO 2027 - MODE OF DELIVERY
9.1. OVERVIEW
9.2. MODE OF DELIVERY MARKET FORECASTS AND ANALYSIS
9.3. BALLOON-EXPANDABLE STENTS AND SELF-EXPANDING STENTS
9.3.1. Overview
9.3.2. Balloon-expandable stents and Self-expanding stents Market Forecast and Analysis
10. BIOENGINEERED STENTS MARKET - REVENUE AND FORECASTS TO 2027 - MATERIAL
10.1. OVERVIEW
10.2. MATERIAL MARKET FORECASTS AND ANALYSIS
10.3. METAL-BASED AND POLYMER-BASED
10.3.1. Overview
10.3.2. Metal-based and Polymer-based Market Forecast and Analysis
11. BIOENGINEERED STENTS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS CARDIAC CENTERS
11.3.1. Overview
11.3.2. Hospitals cardiac centers Market Forecast and Analysis
11.4. AMBULATORY SURGICAL CENTERS AND OTHERS.
11.4.1. Overview
11.4.2. Ambulatory Surgical Centers and others. Market Forecast and Analysis
12. BIOENGINEERED STENTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Bioengineered Stents Market Overview
12.1.2 North America Bioengineered Stents Market Forecasts and Analysis
12.1.3 North America Bioengineered Stents Market Forecasts and Analysis - By Application
12.1.4 North America Bioengineered Stents Market Forecasts and Analysis - By Product
12.1.5 North America Bioengineered Stents Market Forecasts and Analysis - By Mode of Delivery
12.1.6 North America Bioengineered Stents Market Forecasts and Analysis - By Material
12.1.7 North America Bioengineered Stents Market Forecasts and Analysis - By End User
12.1.8 North America Bioengineered Stents Market Forecasts and Analysis - By Countries
12.1.8.1 United States Bioengineered Stents Market
12.1.8.1.1 United States Bioengineered Stents Market by Application
12.1.8.1.2 United States Bioengineered Stents Market by Product
12.1.8.1.3 United States Bioengineered Stents Market by Mode of Delivery
12.1.8.1.4 United States Bioengineered Stents Market by Material
12.1.8.1.5 United States Bioengineered Stents Market by End User
12.1.8.2 Canada Bioengineered Stents Market
12.1.8.2.1 Canada Bioengineered Stents Market by Application
12.1.8.2.2 Canada Bioengineered Stents Market by Product
12.1.8.2.3 Canada Bioengineered Stents Market by Mode of Delivery
12.1.8.2.4 Canada Bioengineered Stents Market by Material
12.1.8.2.5 Canada Bioengineered Stents Market by End User
12.1.8.3 Mexico Bioengineered Stents Market
12.1.8.3.1 Mexico Bioengineered Stents Market by Application
12.1.8.3.2 Mexico Bioengineered Stents Market by Product
12.1.8.3.3 Mexico Bioengineered Stents Market by Mode of Delivery
12.1.8.3.4 Mexico Bioengineered Stents Market by Material
12.1.8.3.5 Mexico Bioengineered Stents Market by End User
12.1.8.4 US Bioengineered Stents Market
12.1.8.4.1 US Bioengineered Stents Market by Application
12.1.8.4.2 US Bioengineered Stents Market by Product
12.1.8.4.3 US Bioengineered Stents Market by Mode of Delivery
12.1.8.4.4 US Bioengineered Stents Market by Material
12.1.8.4.5 US Bioengineered Stents Market by End User
12.2. EUROPE
12.2.1 Europe Bioengineered Stents Market Overview
12.2.2 Europe Bioengineered Stents Market Forecasts and Analysis
12.2.3 Europe Bioengineered Stents Market Forecasts and Analysis - By Application
12.2.4 Europe Bioengineered Stents Market Forecasts and Analysis - By Product
12.2.5 Europe Bioengineered Stents Market Forecasts and Analysis - By Mode of Delivery
12.2.6 Europe Bioengineered Stents Market Forecasts and Analysis - By Material
12.2.7 Europe Bioengineered Stents Market Forecasts and Analysis - By End User
12.2.8 Europe Bioengineered Stents Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Bioengineered Stents Market
12.2.8.1.1 Germany Bioengineered Stents Market by Application
12.2.8.1.2 Germany Bioengineered Stents Market by Product
12.2.8.1.3 Germany Bioengineered Stents Market by Mode of Delivery
12.2.8.1.4 Germany Bioengineered Stents Market by Material
12.2.8.1.5 Germany Bioengineered Stents Market by End User
12.2.8.2 France Bioengineered Stents Market
12.2.8.2.1 France Bioengineered Stents Market by Application
12.2.8.2.2 France Bioengineered Stents Market by Product
12.2.8.2.3 France Bioengineered Stents Market by Mode of Delivery
12.2.8.2.4 France Bioengineered Stents Market by Material
12.2.8.2.5 France Bioengineered Stents Market by End User
12.2.8.3 Italy Bioengineered Stents Market
12.2.8.3.1 Italy Bioengineered Stents Market by Application
12.2.8.3.2 Italy Bioengineered Stents Market by Product
12.2.8.3.3 Italy Bioengineered Stents Market by Mode of Delivery
12.2.8.3.4 Italy Bioengineered Stents Market by Material
12.2.8.3.5 Italy Bioengineered Stents Market by End User
12.2.8.4 Spain Bioengineered Stents Market
12.2.8.4.1 Spain Bioengineered Stents Market by Application
12.2.8.4.2 Spain Bioengineered Stents Market by Product
12.2.8.4.3 Spain Bioengineered Stents Market by Mode of Delivery
12.2.8.4.4 Spain Bioengineered Stents Market by Material
12.2.8.4.5 Spain Bioengineered Stents Market by End User
12.2.8.5 United Kingdom Bioengineered Stents Market
12.2.8.5.1 United Kingdom Bioengineered Stents Market by Application
12.2.8.5.2 United Kingdom Bioengineered Stents Market by Product
12.2.8.5.3 United Kingdom Bioengineered Stents Market by Mode of Delivery
12.2.8.5.4 United Kingdom Bioengineered Stents Market by Material
12.2.8.5.5 United Kingdom Bioengineered Stents Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Bioengineered Stents Market Overview
12.3.2 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis
12.3.3 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By Application
12.3.4 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By Product
12.3.5 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By Mode of Delivery
12.3.6 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By Material
12.3.7 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Bioengineered Stents Market
12.3.8.1.1 Australia Bioengineered Stents Market by Application
12.3.8.1.2 Australia Bioengineered Stents Market by Product
12.3.8.1.3 Australia Bioengineered Stents Market by Mode of Delivery
12.3.8.1.4 Australia Bioengineered Stents Market by Material
12.3.8.1.5 Australia Bioengineered Stents Market by End User
12.3.8.2 China Bioengineered Stents Market
12.3.8.2.1 China Bioengineered Stents Market by Application
12.3.8.2.2 China Bioengineered Stents Market by Product
12.3.8.2.3 China Bioengineered Stents Market by Mode of Delivery
12.3.8.2.4 China Bioengineered Stents Market by Material
12.3.8.2.5 China Bioengineered Stents Market by End User
12.3.8.3 India Bioengineered Stents Market
12.3.8.3.1 India Bioengineered Stents Market by Application
12.3.8.3.2 India Bioengineered Stents Market by Product
12.3.8.3.3 India Bioengineered Stents Market by Mode of Delivery
12.3.8.3.4 India Bioengineered Stents Market by Material
12.3.8.3.5 India Bioengineered Stents Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Bioengineered Stents Market Overview
12.4.2 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis
12.4.3 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By Application
12.4.4 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By Product
12.4.5 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By Mode of Delivery
12.4.6 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By Material
12.4.7 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Bioengineered Stents Market
12.4.8.1.1 South Africa Bioengineered Stents Market by Application
12.4.8.1.2 South Africa Bioengineered Stents Market by Product
12.4.8.1.3 South Africa Bioengineered Stents Market by Mode of Delivery
12.4.8.1.4 South Africa Bioengineered Stents Market by Material
12.4.8.1.5 South Africa Bioengineered Stents Market by End User
12.4.8.2 Saudi Arabia Bioengineered Stents Market
12.4.8.2.1 Saudi Arabia Bioengineered Stents Market by Application
12.4.8.2.2 Saudi Arabia Bioengineered Stents Market by Product
12.4.8.2.3 Saudi Arabia Bioengineered Stents Market by Mode of Delivery
12.4.8.2.4 Saudi Arabia Bioengineered Stents Market by Material
12.4.8.2.5 Saudi Arabia Bioengineered Stents Market by End User
12.4.8.3 U.A.E Bioengineered Stents Market
12.4.8.3.1 U.A.E Bioengineered Stents Market by Application
12.4.8.3.2 U.A.E Bioengineered Stents Market by Product
12.4.8.3.3 U.A.E Bioengineered Stents Market by Mode of Delivery
12.4.8.3.4 U.A.E Bioengineered Stents Market by Material
12.4.8.3.5 U.A.E Bioengineered Stents Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Bioengineered Stents Market Overview
12.5.2 South and Central America Bioengineered Stents Market Forecasts and Analysis
12.5.3 South and Central America Bioengineered Stents Market Forecasts and Analysis - By Application
12.5.4 South and Central America Bioengineered Stents Market Forecasts and Analysis - By Product
12.5.5 South and Central America Bioengineered Stents Market Forecasts and Analysis - By Mode of Delivery
12.5.6 South and Central America Bioengineered Stents Market Forecasts and Analysis - By Material
12.5.7 South and Central America Bioengineered Stents Market Forecasts and Analysis - By End User
12.5.8 South and Central America Bioengineered Stents Market Forecasts and Analysis - By Countries
12.5.8.1 Argentina Bioengineered Stents Market
12.5.8.1.1 Argentina Bioengineered Stents Market by Application
12.5.8.1.2 Argentina Bioengineered Stents Market by Product
12.5.8.1.3 Argentina Bioengineered Stents Market by Mode of Delivery
12.5.8.1.4 Argentina Bioengineered Stents Market by Material
12.5.8.1.5 Argentina Bioengineered Stents Market by End User
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. BIOENGINEERED STENTS MARKET, KEY COMPANY PROFILES
14.1. BOSTON SCIENTIFIC CORPORATION
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ABBOTT LABORATORIES
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BIOTRONIK SE AND CO. KG
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BRAUN MELSUNGEN AG
14.4.1. Key Facts
14.4.2. Businessscription
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. TERUMO CORPORATION
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. MICROPORT SCIENTIFIC CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. STENTYS SA
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. MERIL LIFE SCIENCES PVT. LTD
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. VASCULAR CONCEPTS
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. L. GORE AND ASSOCIATES
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERM
The List of Companies

1. Boston Scientific Corporation
2. Abbott Laboratories
3. Biotronik SE & Co. KG
4. Braun Melsungen AG
5. Terumo Corporation
6. MicroPort Scientific Corporation
7. Stentys SA
8. Meril Life Sciences Pvt. Ltd
9. Vascular Concepts
10. L. Gore and Associates
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book